Biotech entity
All 1 tracked stories fall under one category: pharma. Dr. Mickael Tordjman is most often covered alongside ChatGPT, which appears in 1 of these 1 story. Dr. Mickael Tordjman appears in 1 tracked Biotech story from March 26, 2026. The tracked stories average 2 original sources each.
Last mentioned: Mar 26, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Dr. Mickael Tordjman is most often covered alongside ChatGPT, which appears in 1 of these 1 story. Dr. Mickael Tordjman appears in 1 tracked Biotech story from March 26, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 6 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Dr. Mickael Tordjman. Shared-story counts are live from our verified record — not editorial picks.
A groundbreaking study from the Icahn School of Medicine at Mount Sinai reveals that AI-generated X-rays are indistinguishable from real scans to many human experts and AI models. The findings highlight critical vulnerabilities in medical records that could lead to fraudulent litigation and clinical sabotage.
Dr. Mickael Tordjman is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
